Evidence map›Paper›PMID 31165288›Full record

ArticleMetabolomics : Official journal of the Metabolomic Society2019

Metabolomic signatures of asthma-COPD overlap (ACO) are different from asthma and COPD.

Nilanjana Ghosh, Priyanka Choudhury, Elavarasan Subramani, Dipanjan Saha, Sayoni Sengupta, Mamata Joshi, Rintu Banerjee, Sushmita Roychowdhury, Parthasarathi Bhattacharyya, Koel Chaudhury

Abstract read
PubMed Publisher
In one paragraph

Article in Metabolomics : Official journal of the Metabolomic Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 47 citations in OpenAlex.

  1. Bridging Rare to Common Diseases: Precision Medicine and the Transforming Landscape of Pediatric Allergy and Immunology.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Microbiome modifications by steroids during viral exacerbation of asthma and in healthy mice.American journal of physiology. Lung cellular and molecular physiology · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Air pollution, metabolites and respiratory health across the life-course.European respiratory review : an official journal of the European Respiratory Society · 2022
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Alterations in Serum-Free Amino Acid Profiles in Childhood Asthma.International journal of environmental research and public health · 2020
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Nilanjana GhoshSchool of Medical Science and Technology (SMST), Indian Institute of Technology Kharagpur, Kharagpur, 721302, India.
Priyanka ChoudhurySchool of Medical Science and Technology (SMST), Indian Institute of Technology Kharagpur, Kharagpur, 721302, India.
Elavarasan SubramaniSchool of Medical Science and Technology (SMST), Indian Institute of Technology Kharagpur, Kharagpur, 721302, India.
Dipanjan SahaInstitute of Pulmocare and Research, Kolkata, India.
Sayoni SenguptaInstitute of Pulmocare and Research, Kolkata, India.
Mamata JoshiNational Facility for High-field NMR, Tata Institute of Fundamental Research, Mumbai, India.
Rintu BanerjeeDepartment of Agricultural & Food Engineering, Indian Institute of Technology Kharagpur, Kharagpur, India.
Sushmita RoychowdhuryApollo Gleneagles Hospitals, Kolkata, India.
Parthasarathi BhattacharyyaInstitute of Pulmocare and Research, Kolkata, India.
Koel ChaudhurySchool of Medical Science and Technology (SMST), Indian Institute of Technology Kharagpur, Kharagpur, 721302, India. koel@smst.iitkgp.ac.in.ORCID 0000-0002-9390-1179
Indian Institute of Technology Kharagpur · INApollo Gleneagles Hospitals · INTata Institute of Fundamental Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAsthma-chronic obstructive pulmonary disease (COPD) overlap, termed as ACO, is a complex heterogeneous disease without any clear diagnostic or therapeutic guidelines. The pathophysiology of the disease, its characteristic features, and existence as a unique disease entity remains unclear. Individuals with ACO have a faster lung function decline, more frequent exacerbations, and worse quality of life than those with COPD or asthma alone.

objectivesThe present study aims to determine whether ACO has a distinct metabolic profile in comparison to asthma and COPD.

methodsTwo different groups of patients were recruited as discovery (D) and validation (V) cohorts. Serum samples obtained from moderate and severe asthma patients diagnosed as per GINA guidelines [n = 34(D); n = 32(V)], moderate and severe COPD cases identified by GOLD guidelines [n = 30(D); 32(V)], ACO patients diagnosed by joint GOLD and GINA guidelines [n = 35(D); 40(V)] and healthy controls [n = 33(D)] were characterized using nuclear magnetic resonance (NMR) spectrometry.

resultsMultivariate and univariate analysis indicated that 12 metabolites [lipid, isoleucine, N-acetylglycoproteins (NAG), valine, glutamate, citric acid, glucose, L-leucine, lysine, asparagine, phenylalanine and histidine] were dysregulated in ACO patients when compared with both asthma and COPD. These metabolites were further validated in a fresh cohort of patients, which again exhibited a similar expression pattern.

conclusionsOur findings suggest that ACO has an enhanced energy and metabolic burden associated with it as compared to asthma and COPD. It is anticipated that our results will stimulate researchers to further explore ACO and unravel the pathophysiological complexities associated with the disease.

Indexed as

MetabolomeAdultAsthmaAsthma-Chronic Obstructive Pulmonary Disease Overlap SyndromeCohort StudiesFemaleHumansMaleMetabolomicsMiddle AgedPulmonary Disease, Chronic ObstructiveAsthma-COPD overlapBiomarkersMetabolomicsNMRSerum

Identifiers

PMID31165288
OpenAlexW2948429638

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.